Ling Zeng, Esq.

Ling Zeng joined Omega Therapeutics as Chief Legal and Administrative Officer and brings considerable experience in healthcare policy and regulation. Prior to joining Omega, Ms. Zeng was most recently Chief Legal Officer and Secretary of Dicerna Pharmaceuticals, where she worked alongside other executives, the board of directors and their committees to develop and implement company strategy, policy, governance, and compliance. Earlier, Ms. Zeng served as Deputy Head Legal, Group Mergers and Acquisitions, at Novartis AG, where she was responsible for global transactions across the Novartis Group.

Previously, Ms. Zeng held various legal executive roles of increasing responsibility at Bausch Health Companies, Inc., Penwest Pharmaceuticals Co. and Barr Laboratories, Inc. In these roles, Ms. Zeng was responsible for providing sound counsel on public company governance, compliance, enterprise risk management, development and commercial operations, strategic transactions, healthcare industry regulations and IP portfolio management and strategy. Ms. Zeng began her legal career at Cleary, Gottlieb, Steen and Hamilton and, prior to that, also spent time as a researcher at Alkermes Inc. and LeukoSite Inc.

Ms. Zeng received her B.S. in Physics from Peking University, M.S. in Biophysics from Brandeis University and Juris Doctor in Law from Georgetown University.